dc.creator | Moschos M.M., Laios K., Androudi S., Ladas D.S., Chatziralli I.P. | en |
dc.date.accessioned | 2023-01-31T09:01:30Z | |
dc.date.available | 2023-01-31T09:01:30Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.1080/15569527.2017.1409754 | |
dc.identifier.issn | 15569527 | |
dc.identifier.uri | http://hdl.handle.net/11615/76761 | |
dc.description.abstract | Objective: The purpose of this experimental study was to investigate the role of vitamin supplements (Ocuvite, Vitalux Omega, and Nutrof Total) as possible inhibitors of the onset of age-related macular degeneration (AMD). Materials and methods: The anti-aggregating effect of each vitamin was determined against four accumulative factors namely, platelet activating factor (PAF), adenosine diphosphate (ADP), thrombin receptor-activating peptide (TRAP), and arachidonic acid (AA) in the platelet rich plasma (PRP) of healthy volunteers. Results: Ocuvite, Vitalux Omega, and Nutrof Total were more potent inhibitors against PAF and ADP compared to TRAP and AA. Among the three vitamins, Nutrof Total displayed more potent inhibitions against TRAP and AA, while against PAF and ADP all the three vitamins revealed similar IC50 values. Conclusions: The vitamins Ocuvite, Vitalux Omega, and Nutrof Total have anti-aggregating effects and therefore can be used against AMD in healthy volunteers. © 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. | en |
dc.language.iso | en | en |
dc.source | Cutaneous and Ocular Toxicology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038030953&doi=10.1080%2f15569527.2017.1409754&partnerID=40&md5=2caea4748f56f6d95cdf0bba75c00e09 | |
dc.subject | adenosine diphosphate | en |
dc.subject | alpha tocopherol | en |
dc.subject | arachidonic acid | en |
dc.subject | ascorbic acid | en |
dc.subject | copper | en |
dc.subject | docosahexaenoic acid | en |
dc.subject | glutathione | en |
dc.subject | hydrocarbon | en |
dc.subject | icosapentaenoic acid | en |
dc.subject | lipid | en |
dc.subject | nutrof total | en |
dc.subject | ocuvite | en |
dc.subject | omega 3 fatty acid | en |
dc.subject | protein | en |
dc.subject | resveratrol | en |
dc.subject | selenium | en |
dc.subject | thrombin receptor activating peptide | en |
dc.subject | thrombocyte activating factor | en |
dc.subject | vitalux omega | en |
dc.subject | vitamin | en |
dc.subject | xanthophyll | en |
dc.subject | zeaxanthin | en |
dc.subject | zinc | en |
dc.subject | thrombin receptor | en |
dc.subject | vitamin | en |
dc.subject | age related macular degeneration | en |
dc.subject | anticoagulation | en |
dc.subject | Article | en |
dc.subject | drug potency | en |
dc.subject | experimental study | en |
dc.subject | human | en |
dc.subject | human cell | en |
dc.subject | IC50 | en |
dc.subject | in vitro study | en |
dc.subject | thrombocyte aggregation | en |
dc.subject | thrombocyte rich plasma | en |
dc.subject | vitamin supplementation | en |
dc.subject | antagonists and inhibitors | en |
dc.subject | comparative study | en |
dc.subject | dietary supplement | en |
dc.subject | drug effect | en |
dc.subject | macular degeneration | en |
dc.subject | metabolism | en |
dc.subject | normal human | en |
dc.subject | physiology | en |
dc.subject | thrombocyte | en |
dc.subject | Adenosine Diphosphate | en |
dc.subject | Arachidonic Acid | en |
dc.subject | Blood Platelets | en |
dc.subject | Dietary Supplements | en |
dc.subject | Healthy Volunteers | en |
dc.subject | Humans | en |
dc.subject | Inhibitory Concentration 50 | en |
dc.subject | Macular Degeneration | en |
dc.subject | Platelet Activating Factor | en |
dc.subject | Platelet Aggregation | en |
dc.subject | Receptors, Thrombin | en |
dc.subject | Vitamins | en |
dc.subject | Taylor and Francis Ltd | en |
dc.title | Anti-platelet effects of vitamin supplements in age-related macular degeneration: an in vitro study | en |
dc.type | journalArticle | en |